StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 28, 2026, 05:26 PM

Jupiter Neurosciences Sells $3.6M Common Stock to Yorkville

AI Summary

Jupiter Neurosciences, Inc. announced the sale of 11,470,000 shares of its Common Stock to YA II PN, Ltd. (Yorkville) between May 14, 2026, and July 24, 2026. These sales, conducted under a Standby Equity Purchase Agreement (SEPA), generated aggregate gross proceeds of approximately $3.6 million. The shares were issued at 97% of the lowest daily volume-weighted average price during the pricing period, and as of July 28, 2026, the company has 56,520,143 shares outstanding.

Key Highlights

  • Jupiter Neurosciences sold 11,470,000 common shares to Yorkville.
  • Sales occurred between May 14, 2026, and July 24, 2026.
  • Aggregate gross proceeds from these sales totaled approximately $3.6 million.
  • Shares were sold under a Standby Equity Purchase Agreement (SEPA).
  • The per-share purchase price was 97% of the lowest daily volume-weighted average price (VWAP).
  • As of July 28, 2026, the company has 56,520,143 shares of Common Stock outstanding.
  • The shares were issued in reliance on Section 4(a)(2) and Rule 506(b) exemptions.